Cordlife Group Limited (SGX:P8A)

Singapore · Delayed Price · Currency is SGD

0.1320

0.00 (0.00%)

Sep 7, 2026, 7:13 PM SGT

Market Cap	33.83M -41.3%
Revenue (ttm)	36.96M -1.8%
Net Income	-10.69M
EPS	-0.04
Shares Out	256.31M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Open	0.1100
Previous Close	0.1320
Day's Range	0.1100 - 0.1320
52-Week Range	0.1050 - 0.2600
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Cordlife Group

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test ... [Read more]

Industry Medical - Diagnostics & Research

Sector Healthcare

Founded 2001

Employees 538

Stock Exchange Singapore Exchange

Ticker Symbol P8A

Full Company Profile

Financial Performance

In 2025, Cordlife Group's revenue was 38.85 million, an increase of 40.53% compared to the previous year's 27.65 million. Losses were -12.64 million, -33.06% less than in 2024.

Financial Statements